Effect of dietary lipid-lowering drugs upon plasma lipids and egg yolk cholesterol levels of laying hens

Journal of Agricultural and Food Chemistry

Volumn 47, Issue 11, 1999, Pages 4731-4735

  Mori, Agnes V ^a   Mendonça Jr , Cassio X ^a   Santos, Cristiane O F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cholesterol; Egg yolk; Hens; Lipid lowering drugs; Lipids

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; GEMFIBROZIL; HYPOCHOLESTEROLEMIC AGENT; LIPID; MEVINOLIN; PROBUCOL; TRIACYLGLYCEROL;

ANIMAL; ANIMAL MODEL; ARTICLE; BLOOD; CHEMISTRY; CHICKEN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFECT; EGG; EGG YOLK; FEMALE; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; NONHUMAN; TREATMENT OUTCOME;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CHICKENS; CHOLESTEROL; DIETARY SUPPLEMENTS; EGG YOLK; FEMALE; GEMFIBROZIL; LIPIDS; LOVASTATIN; PROBUCOL; TRIGLYCERIDES;

EID: 0033231179     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf990481+     Document Type: Article

References (28)

1. Arad, Y.; Ramakrishnan, R.; Ginsberg, H. N. Lovastatin therapy reduces low-density lipoprotein apo-B levels in subjects with combined hyperlipidemia by reducing the production of apo-B containing lipoproteins: implications for the pathophysiology of apo-B production. J. Lipid Res. 1990, 31, 567-582.
2. Barnhart, J. M.; Sefranka, J. A.; McIntosh, D. D. Hypocholesterolemic effect of 4,4′-(isopropylidenedithio)bis(2,6-di-t-butylphenol) (probucol). Am. J. Clin. Nutr. 1970, 23, 1229-1233.
3. Bertolami, M. C. Drogas nas hiperlipidemias. In Colesterol e Aterosclerose; Quintão, E. C. R., Ed.; Qualitymark: Rio de Janeiro, RJ, 1992; pp 195-224.
4. Beyer, R. S.; Jensen, L. S. Overestimation of the cholesterol content of eggs. J. Agric. Food Chem. 1989, 37, 917-920.
5. Briz, R. C. Ovos com teores mais elevados de ácidos graxos ômega 3. In VII Simpósio Técnico de Produção de Ovos; Associação Paulista de Avicultura (APA): São Paulo, 1997; pp 153-193.
6. Elkin, R. R.; Rogler, J. C. Reduction of the cholesterol content of eggs by the oral administration of lovastatin to laying hens. J. Agric. Food Chem. 1990, 38, 1635-1641.
7. Griffin, H. D. Manipulation of egg yolk cholesterol: a physiologist's review. World's Poult. Sci. J. 1992, 48, 101-112.
8. Griminger, P. Lipid metabolism. In Avian Physiology, 4th ed.; Sturkie, P. D., Eds.; Springer-Verlag: New York, 1986; pp 345-358.
9. Grundy, S. M. Atlas of lipid disorders - Drug therapy of hyperlipidemia; Gower Medical: New York, 1990.
10. Grundy, S. M. What is the desirable ratio of saturated, polyunsaturated, and monounsaturated fatty acids in the diet? Am. J. Clin. Nutr. 1997, 66, 988S-990S.
11. Hamill, T. W.; Soliman, A. M. Determination of cholesterol by p-nitrobenzoate derivatization and liquid chromatography. J. AOAC Int. 1994, 77, 1190-1196.
12. Hamilton, R. M. G. Methods and factors that affect the measurement of egg shell quality. Poult. Sci. 1982, 61, 2022-2039.
13. Hargis, P. S. Modifying egg yolk cholesterol in the domestic fowl - a review. World's Poult. Sci. J. 1988, 44, 17-29.
14. Jiang, Z.; Fenton, M.; Sim, J. S. Comparison of four different methods for egg cholesterol determination. Poult. Sci. 1991, 70, 1015-1019.
15. Jones, P. H.; Pownall, H. J.; Patsch, W.; Herd, A.; Farmer, J. A.; Payton-Ross, C.; Kimball, K. T.; Gotto, A. M.; Morrisett, J. D. Effect of gemfibrozil on levels of lipoprotein [a] in type II hyperlipoproteinemic subjects. J. Lipid Res. 1996, 37, 1298-1308.
16. Khan, B.; Wilcox, H. B.; Heimberg, M. Cholesterol is required for secretion of very low density lipoprotein by rat liver. Biochem. J. 1989, 258, 807-816.
17. Krause, B. R.; Newton, R. S. Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats. J. Lipid Res. 1985, 26, 940-949.
18. Luhman, C. M.; Miller, B. G.; Beitz, D. C. The effect of feeding lovastatin and colestipol on production and cholesterol egg content of eggs. Poult. Sci. 1990, 69, 852-855.
19. Naber, E. C.; Elliot, J. F.; Smith, T. L. Effect of probucol on reproductive performance, egg yolk cholesterol content, and lipid metabolism in the laying hen. Poult. Sci. 1982, 61, 1118-1124.
20. Naber, E. C. Cholesterol content of eggs: can and should the industry try to change it? Feedstuffs 1990, 62, 46-52.
21. National Research Council. Nutrient Requirements of Poultry, 9th ed.; National Academy Press: Washington, DC, 1994.
22. Noble, R. C. Egg lipids. In Egg Quality-Current Problems and Recent Advances; Wells, R. G., Belyavin, C. G., Eds.; Butterworths: London, 1987; pp 159-177.
23. SAS Institute. SAS User Guide: Statistics; SAS Institute Inc.: Cary, NC, 1985.
24. Sauveur, B. Reproduction des volailles et production d'oeüfs; INRA: Paris, 1988; p 385.
25. Tobert, J. A.; Bell, G. D.; Birtwell, J.; James, I.; Kukovetz, W. R.; Pryor, J. S.; Buntinx, A.; Holmes, I. B.; Chao, Y. S.; Bolognese, J. A. Cholesterol-lowering effect of Mevinolin, an inhibitor of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, in healthy volunteers. J. Clin. Invest. 1982, 69, 913-919.
26. Todd, P. A.; Ward, A. Gemfibrozil - A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia. Drugs 1988, 36, 314-339.
27. Waldroup, P. W.; Ndife, L. I.; Hellwig, H. M. Influence of probucol ((4,4′-isopropylidine dithio)bis(2,6-di-t-butyl-phenol)) on egg yolk cholesterol content and performance of laying hens. Poult. Sci. 1986, 65, 1949-1954.
28. Weiss, J. F.; Johnson, R. M.; Naber, E. C. Effect of some dietary factors and drugs on cholesterol concentration in the egg and plasma of the hen. J. Nutr. 1967, 91, 119-128.